Catalyst
Slingshot members are tracking this event:
Lilly (LLY)'s Clinical Efficacy, Safety and Patient-Reported Outcomes Data of Baricitinib in Patients with Rheumatoid Arthritis will be presented at 2016 American College of Rheumatology Annual Meeting, November 11-16, 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LLY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Occurred Source:
http://lilly.mediaroom.com/index.php?s=9042&item=137602
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Baricitinib, Rheumatoid Arthritis
